Ceruloplasmin/transferrin ratio changes in Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Squitti, Rosanna ^a,b   Salustri, Carlo ^c   Siotto, Mariacristina ^b   Ventriglia, Mariacarla ^a,b   Vernieri, Fabrizio ^b   Lupoi, Domenico ^c   Cassetta, Emanuele ^a   Rossini, Paolo M ^b,d  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d Department of Imaging San Raffaele Cassino ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; IRON; PEROXIDE; TRANSFERRIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; TEMPORAL LOBE; TRANSFERRIN BLOOD LEVEL;

EID: 79952120585     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/231595     Document Type: Article

References (51)

1. Kirkitadze M. D., Kowalska A., Molecular mechanisms initiating amyloid -fibril formation in (Pubitemid 41133776)
2. Blacker D., Haines J. L., Rodes L., Terwedow H., Go R. C. P., Harrell L. E., Perry R. T., Bassett S. S., Chase G., Meyers D., Albert M. S., Tanzi R., ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative Neurology 1997 48 1 139 147 (Pubitemid 27039532)
3. Lavados M., Guilln M., Mujica M. C., Rojo L. E., Fuentes P., Maccioni R. B., Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron Journal of Alzheimer's Disease 2008 13 2 225 232 (Pubitemid 352038527)
4. Smith M. A., Zhu X., Tabaton M., Liu G., McKeel D. W., Cohen M. L., Wang X., Siedlak S. L., Dwyer B. E., Hayashi T., Nakamura M., Nunomura A., Perry G., Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment Journal of Alzheimer's Disease 2010 19 1 363 372
5. Bartzokis G., Tishler T. A., MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease Cellular and Molecular Biology 2000 46 4 821 833
6. Ding B., Chen KE. M., Ling H. W., Sun F., Li X., Wan T., Chai W. M., Zhang H., Zhan Y., Guan Y. J., Correlation of iron in the hippocampus with MMSE in patients with alzheimer's disease Journal of Magnetic Resonance Imaging 2009 29 4 793 798
7. Loeffler D. A., Connor J. R., Juneau P. L., Snyder B. S., Kanaley L., DeMaggio A. J., Nguyen H., Brickman C. M., LeWitt P. A., Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions Journal of Neurochemistry 1995 65 2 710 724
8. Schenck J. F., Zimmerman E. A., Li Z., Adak S., Saha A., Tandon R., Fish K. M., Belden C., Gillen R. W., Barba A., Henderson D. L., Neil W., O'Keefe T., High-field magnetic resonance imaging of brain iron in Alzheimer disease Topics in Magnetic Resonance Imaging 2006 17 1 41 50 (Pubitemid 46672932)
9. Cornett C. R., Markesbery W. R., Ehmann W. D., Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain NeuroToxicology 1998 19 3 339 346 (Pubitemid 28264756)
10. Deibel M. A., Ehmann W. D., Markesbery W. R., Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress Journal of the Neurological Sciences 1996 143 1-2 137 142 (Pubitemid 26402800)
11. Dedman D. J., Treffry A., Candy J. M., Taylor G. A. A., Morris C. M., Bloxham C. A., Perry R. H., Edwardson J. A., Harrison P. M., Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients Biochemical Journal 1992 287 2 509 514
12. Connor J. R., Snyder B. S., Beard J. L., Fine R. E., Mufson E. J., Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease Journal of Neuroscience Research 1992 31 2 327 335
13. Good P. F., Perl D. P., Bierer L. M., Schmeidler J., Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study Annals of Neurology 1992 31 3 286 292
14. Jellinger K., Paulus W., Grundke-Iqbal I., Riederer P., Youdim M. B. H., Brain iron and ferritin in Parkinson's and Alzheimer's diseases Journal of Neural Transmission: Parkinson's Disease and Dementia Section 1990 2 4 327 340
15. Morris C. M., Kerwin J. M., Edwardson J. A., Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus Neurodegeneration 1994 3 4 267 275
16. Loeffler D. A., LeWitt P. A., Juneau P. L., Sima A. A. F., Nguyen H. U., DeMaggio A. J., Brickman C. M., Brewer G. J., Dick R. D., Troyer M. D., Kanaley L., Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders Brain Research 1996 738 2 265 274 (Pubitemid 26378921)
17. Castellani R. J., Smith M. A., Nunomura A., Harris P. L. R., Perry G., Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radical Biology and Medicine 1999 26 11-12 1508 1512 (Pubitemid 29302284)
18. Connor J. R., Tucker P., Johnson M., Snyder B., Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease Neuroscience Letters 1993 159 1-2 88 90 (Pubitemid 23283245)
19. Connor J. R., Menzies S. L., Martin S. M. ST., Mufson E. J., A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains Journal of Neuroscience Research 1992 31 1 75 83
20. McKhann G., Drachman D., Folstein M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 1984 34 7 939 944 (Pubitemid 14076461)
21. Folstein M. F., Folstein S. E., McHugh P. R., Mini mental state. A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 1975 12 3 189 198
22. Squitti R., Pasqualetti P., Dal Forno G., Moffa F., Cassetta E., Lupoi D., Vernieri F., Rossi L., Baldassini M., Rossini P. M., Excess of serum copper not related to ceruloplasmin in Alzheimer disease Neurology 2005 64 6 1040 1046 (Pubitemid 40388458)
23. Squitti R., Rossini P. M., Cassetta E., Moffa F., Pasqualetti P., Cortesi M., Colloca A., Rossi L., Finazzi-Agr A., D-penicillamine reduces serum oxidative stress in Alzheimer's disease patients European Journal of Clinical Investigation 2002 32 1 51 59 (Pubitemid 36228383)
24. Hixson J. E., Vernier D. T., Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI Journal of Lipid Research 1990 31 3 545 548 (Pubitemid 20107994)
25. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H. C., Vermersch P., Kuiper M., Steinling M., Wolters E. C., Valk J., Atrophy of medial temporal lobes on MRI in probable Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates Journal of Neurology Neurosurgery and Psychiatry 1992 55 10 967 972
26. Scheltens P., Launer L. J., Barkhof F., Weinstein H. C., Van Gool W. A., Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability Journal of Neurology 1995 242 9 557 560
27. Scheltens P., Erkinjunti T., Leys D., Wahlund L. O., Inzitari D., Del Ser T., Pasquier F., Barkhof F., Mntyl R., Bowler J., Wallin A., Ghika J., Fazekas F., Pantoni L., White matter changes on CT and MRI: an overview of visual rating scales European Neurology 1998 39 2 80 89 (Pubitemid 28069798)
28. Erkinjuntti T., Inzitari D., Pantoni L., Wallin A., Scheltens P., Rockwood K., Roman G. C., Chui H., Desmond D. W., Research criteria for subcortical vascular dementia in clinical trials Journal of Neural Transmission, Supplement 2000 59 23 30 (Pubitemid 30479402)
29. Bartels E., Color-Coded Duplex Ultrasonography of the Cerebral Vessels: Atlas and Manual 1999 Stuttgart, Germany Schattauer
30. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., Rossini P. M., Elevation of serum copper levels in Alzheimer's disease Neurology 2002 59 8 1153 1161 (Pubitemid 35192384)
31. O'Leary D. H., Polak J. F., Kronmal R. A., Manolio T. A., Burke G. L., Wolfson S. K. Jr., Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults New England Journal of Medicine 1999 340 1 14 22 (Pubitemid 29024679)
32. Aaslid R., Markwalder T. M., Nornes H., Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries Journal of Neurosurgery 1982 57 6 769 774 (Pubitemid 13208286)
33. Altamura C., Squitti R., Pasqualetti P., Gaudino C., Palazzo P., Tibuzzi F., Lupoi D., Cortesi M., Rossini P. M., Vernieri F., Ceruloplasmin/Transferrin system is related to clinical status in acute stroke Stroke 2009 40 4 1282 1288
34. Duce J. A., Tsatsanis A., Cater M. A., James S. A., Robb E., Wikhe K., Leong S. L., Perez K., Johanssen T., Greenough M. A., Cho H. -H., Galatis D., Moir R. D., Masters C. L., McLean C., Tanzi R. E., Cappai R., Barnham K. J., Ciccotosto G. D., Rogers J. T., Bush A. I., Iron-export ferroxidase activity of -amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 2010 142 6 857 867
35. White A. R., Reyes R., Mercer J. F. B., Camakaris J., Zheng H., Bush A. I., Multhaup G., Beyreuther K., Masters C. L., Cappai R., Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice Brain Research 1999 842 2 439 444 (Pubitemid 29475178)
36. Kozlov A. V., Sergienko V. I., Vladimirov I. A., Azizova O. A., The antioxidant system of transferrin-ceruloplasmin in experimental hypercholesterolemia Byulleten Eksperimentalnoi Biologii i Meditsiny 1984 98 12 668 671
37. Aksoy H., Taysi S., Altinkaynak K., Bakan E., Bakan N., Kumtepe Y., Antioxidant potential and transferrin, ceruloplasmin, and lipid peroxidation levels in women with preeclampsia Journal of Investigative Medicine 2003 51 5 284 287 (Pubitemid 37210889)
38. Serdar Z., Gr E., Develiolu O., Serum iron and copper status and oxidative stress in severe and mild preeclampsia Cell Biochemistry and Function 2006 24 3 209 215 (Pubitemid 43764456)
39. Fleming R. E., Migas M. C., Holden C. C., Waheed A., Britton R. S., Tomatsu S., Bacon B. R., Sly W. S., Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis Proceedings of the National Academy of Sciences of the United States of America 2000 97 5 2214 2219 (Pubitemid 30134048)
40. Burdo J. R., Antonetti D. A., Wolpert E. B., Connor J. R., Mechanisms and regulation of transferrin and iron transport in a model blood-brain barrier system Neuroscience 2003 121 4 883 890 (Pubitemid 37324587)
41. Alizadeh B. Z., Njajou O. T., Milln M. R., Hofman A., Breteler M. M., van Duijn C. M., HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam Study Neurobiology of Aging 2009 30 2 330 332
42. Blzquez L., De Juan D., Ruiz-Martnez J., Emparanza J. I., Senz A., Otaegui D., Sistiaga A., Martnez-Lage P., Lamet I., Samaranch L., Buiza C., Etxeberria I., Arriola E., Cuadrado E., Urdaneta E., Yanguas J., Lpez de Munain A., Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population Neurobiology of Aging 2007 28 12 1941 1943 (Pubitemid 47539694)
43. Berlin D., Chong G., Chertkow H., Bergman H., Phillips N. A., Schipper H. M., Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI Neurobiology of Aging 2004 25 4 465 474 (Pubitemid 38317344)
44. Robson K. J. H., Lehmann D. J., Wimhurst V. L. C., Livesey K. J., Combrinck M., Merryweather-Clarke A. T., Warden D. R., Smith A. D., Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease Journal of Medical Genetics 2004 41 4 261 265 (Pubitemid 38496768)
45. Sampietro M., Caputo L., Casatta A., Meregalli M., Pellagatti A., Tagliabue J., Annoni G., Vergani C., The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease Neurobiology of Aging 2001 22 4 563 568 (Pubitemid 32607740)
46. Lehmann D. J., Worwood M., Ellis R., Wimhurst V. L., Merryweather-Clarke A. T., Warden D. R., Smith A. D., Robson K. J., Iron genes, iron load and risk of Alzheimer's disease Journal of medical genetics 2006 43 10, article e52
47. Halliwell B., Free radicals and metal ions in health and disease Proceedings of the Nutrition Society 1987 46 1 13 26
48. Van Rensburg S. J., Van Zyl J., Hon D., Daniels W., Hendricks J., Potocnik F., Erasmus R., Biochemical model for inflammation of the brain: the effect of iron and transferrin on monocytes and lipid peroxidation Metabolic Brain Disease 2004 19 1-2 97 112 (Pubitemid 39005629)
49. Scacchi R., De Bernardini L., Mantuano E., Donini L. M., Vilardo T., Corbo R. M., Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of 4 allele with AD in Italian octogenarian patients Neuroscience Letters 1995 201 3 231 234
50. De la Torre J. C., Alzheimer disease as a vascular disorder: nosological evidence Stroke 2002 33 4 1152 1162
51. Salustri C., Tecchio F., Zappasodi F., Bevacqua G., Fontana M., Ercolani M., Milazzo D., Squitti R., Rossini P. M., Cortical excitability and rest activity properties in patients with depression Journal of Psychiatry and Neuroscience 2007 32 4 259 266 (Pubitemid 47057459)